Guidelines of care for cutaneous lupus erythematosus

Journal of the American Academy of Dermatology

Volumn 34, Issue 5 I, 1996, Pages 830-836

  Drake, Lynn A ^b   Dinehart, Scott M ^b   Farmer, Evan R ^b   Goltz, Robert W ^b   Graham, Gloria F ^b   Hordinsky, Maria K ^b   Lewis, Charles W ^b   Pariser, David M ^b   Skouge, John W ^b   Webster, Stephen B ^b   Whitaker, Duane C ^b   Butler, Barbara ^b   Lowery, Barbara J ^b  

^a AMERICAN ACADEMY OF DERMATOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; AMINOQUINOLINE DERIVATIVE; AURANOFIN; AUROTHIOMALATE; AZATHIOPRINE; CHLOROQUINE; CLOFAZIMINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETRETINATE; HYDROXYCHLOROQUINE; ISOTRETINOIN; MEPACRINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RETINOID; SUNSCREEN; THALIDOMIDE; TRIAMCINOLONE ACETONIDE;

CLINICAL EXAMINATION; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS;

EID: 15844431966     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90039-0     Document Type: Article

References (30)

1. Bangert JL, Freeman RG, Sontheimer RD, et al. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus: comparative histopathologic findings. Arch Dermatol 1984;120:332-7.
2. Callen JP, Spencer LV, Burruss JB, et al. Azathioprine: an effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 1991; 127:515-22.
3. Crovato F, Levi L. Clofazimine in the treatment of annular lupus erythematosus. Arch Dermatol 1981;117:249-50.
4. Dalziel K, Going G, Cartwright PH, et al. Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin). Br J Dermatol 1986;115:211-6.
5. Drake LA, Ceilley RI, Cornelison RL. Guidelines of care for acne vulgaris. J AM ACAD DERMATOL 1990;22:676-80.
6. Drake LA, Ceilley RI, Cornelison RL. Guidelines of care for psoriasis. J AM ACAD DERMATOL 1993;28:632-7.
7. Dubois EL. Antimalarials in the management of discoid and systemic lupus erythematosus. Semin Arthritis Rheum 1978; 8:33-51.
8. Fenton DA, Black MM. Low-dose dapsone in the treatment of subacute cutaneous lupus erythematosus. Clin Exp Dermatol 1986;11:102-3.
9. Furner BB. Treatment of subacute cutaneous lupus erythematosus. Int J Dermatol 1990;29:542-7.
10. Goldberg JW, Lidsky MD. Pulse methylprednisolone therapy for persistent subacute cutaneous lupus. Arthritis Rheum 1984;27:837-8.
11. Jerdan MS, Hood AF, Moore GW, et al. Histopathologic comparison of the subsets of lupus erythematosus. Arch Dermatol 1990;126:52-5.
12. Knop J, Bonsmann G, Happle R, et al. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol 1983;108:461-6.
13. McCauliffe DP, Sontheimer RD. Subacute cutaneous lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus erythematosus. Philadelphia: Lea & Febiger, 1993:302-9.
14. McCormack LS, Elgart ML, Turner MLC. Annular subacute cutaneous lupus erythematosus responsive to dapsone. J AM ACAD DERMATOL 1984;11:397-401.
15. Naafs B, Bakkers EJ, Flinterman J, et al. Thalidomide treatment of subacute cutaneous lupus erythematosus. Br J Dermatol 1982;107:83-6.
16. Newton RC, Jorizzo JL, Solomon AR, et al. Mechanism-oriented assessment of isotretinoin in chronic or subacute lupus erythematosus. Arch Dermatol 1986;122:170-6.
17. Nicholas JF, Thivolet J, Kanitakis J, et al. Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2A. J Invest Dermatol 1990;95(suppl):142S-5S.
18. Physicians' Desk Reference. New Jersey: Medical Economics, 1995.
19. Ratner D, Skouge J. Discoid lupus erythematosus scarring and dermabrasion: a case report and discussion. J AM ACAD DERMATOL 1990;22:314-6.
20. Rothe MJ, Kerdel FA. Treatment of cutaneous lupus erythematosus. Lupus 1992;1:351-6.
21. Ruzicka T, Goerz G. Dapsone in the treatment of lupus erythematosus. Br J Dermatol 1981;104:53-6.
22. Ruzicka T, Meurer M, Bieber T. Efficiency of acitretin in the treatment of cutaneous lupus erythematosus. Arch Dermatol 1988;124:897-902.
23. Ruzicka T, Meurer M, Braun-Falco O. Treatment of cutaneous lupus erythematosus with etretinate. Acta Derm Venereol (Stockh) 1985;65:324-9.
24. Sontheimer RD. Clinical manifestations of cutaneous lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus erythematosus. Philadelphia: Lea & Febiger, 1993:285-301.
25. Sontheimer RD. Lupus erythematosus. In: Provost TT, Farmer ER, eds. Current therapy in dermatology - 2. Philadelphia: BC Becker, 1988:123-8.
26. Sontheimer RD. Subacute cutaneous lupus erythematosus: a decade's perspective. Med Clin North Am 1989;73:1073-90.
27. Sontheimer RD, McCauliffe DP, Zappi E, et al. Antinuclear antibodies: clinical correlations and biologic significance. Adv Dermatol 1992;7:3-52.
28. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
29. Volc-Platzer B, Wolff K. Treatment of subacute cutaneous lupus erythematosus with thalidomide. Hautarzt 1983; 34:175-8.
30. Wallace DJ. The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination. Semin Arthritis Rheum 1989;18:282-96.